A systemic approach to SjD At Johnson & Johnson, we are currently exploring an investigational therapy for the treatment of SjD. This research is reflective of Johnson & Johnson’s ongoing commitment to better assess the pathophysiology of autoantibody-driven diseases and identify and target their underlying cause. Prioritizing patient perspectives Alongside…
Sponsored Content
Recent Posts
- AI tools find 12 biomarkers that may speed a Sjögren’s diagnosis
- A closer look at Sjögren’s disease: How Johnson & Johnson is driving patient-informed research
- Investment funds development of ‘Goldilocks’ treatment for dry eyes
- AI system may accurately diagnose Sjögren’s using routine lab tests: Study
- FDA grants breakthrough status to experimental Sjögren’s drug ianalumab
- New study uses artificial intelligence to uncover Sjögren’s disease subtypes
- Blood molecule may offer new way to detect and track Sjögren’s disease
- Childhood-onset Sjögren’s can cause lasting damage to organs: Study
- Salivary duct treatment eases dry mouth in Sjögren’s disease: Study
- 4 genes linked to inflammatory cell death very active in Sjögren’s